Market Place
Sourcing Support
Menlo Therapeutics Announces Pricing of Offering of Common Stock
05 Jun 2020 //
GLOBENEWSWIRE
Menlo Therapeutics Announces Positive Results from Phase 2 Trial of FCD105
02 Jun 2020 //
GLOBENEWSWIRE
Menlo Therapeutics Receives FDA Approval of ZILXI™ (minocycline) topical foam
29 May 2020 //
PRNEWSWIRE
Menlo Therapeutics Announces Covered Status for AMZEEQ®
27 May 2020 //
GLOBENEWSWIRE
Menlo & Cutia Therapeutics Enter into Exclusive License Agreement for AMZEEQ™
23 Apr 2020 //
GLOBENEWSWIRE
Menlo hit with serlopitant setback
07 Apr 2020 //
PHARMATIMES
A pair of PhIII failures spells last rites for Menlo’s once-promising Merck drug
06 Apr 2020 //
ENDPTS
Menlo Therapeutics and Foamix Pharmaceuticals Complete Merger
09 Mar 2020 //
PR NEWSWIRE
Menlo Therapeutics Announces Results from Phase 2 Trial of Serlopitant
27 Feb 2020 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.